Pfizer Again Ditches Plan to Split Into 2 Businesses
Pfizer said Monday it will not pursue a plan to split into two separate, publicly traded business, after indicating in April the U.S. pharmaceutical giant would again start weighing the plan...To view the full article, register now.
Already a subscriber? Click here to view full article